CervoMed Statistics
Want to see CRVO full AI Analyst Report?
CervoMed (CRVO) Stock Statistics & Valuation Metrics
Total Valuation
CervoMed has a market cap or net worth of $20.12M. The enterprise value is $25.31M.
- Market Cap
- $20.12M
- Enterprise Value
- $25.31M
Share Statistics
CervoMed has 15,128,540 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 15,128,540
- Owned by Insiders
- 33.94%
- Owned by Institutions
- 9.17%
Financial Efficiency
CervoMed’s return on equity (ROE) is -1.48 and return on invested capital (ROIC) is -155.27%.
- Return on Equity (ROE)
- -1.48
- Return on Assets (ROA)
- -1.18
- Return on Invested Capital (ROIC)
- -155.27%
- Return on Capital Employed (ROCE)
- -1.55
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.80M
- Employee Count
- 15
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of CervoMed is -0.53. CervoMed’s PEG ratio is -0.71.
- PE Ratio
- -0.53
- PS Ratio
- 0.00
- PB Ratio
- 1.27
- Price to FCF
- -0.83
- Price to Operating Cash Flow
- -0.83
- PEG Ratio
- -0.71
Income Statement
In the last 12 months, CervoMed had revenue of 0 and earned -26.97M in profits. Earnings per share was -2.98.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -28.29M
- Pretax Income
- -26.97M
- Net Income
- -26.97M
- EBITDA
- -26.97M
- Earnings Per Share (EPS)
- -2.98
Cash Flow
In the last 12 months, operating cash flow was -26.59M and capital expenditures 0, giving a free cash flow of -26.59M billion.
- Operating Cash Flow
- -26.59M
- Free Cash Flow
- -26.59M
- Free Cash Flow per Share
- -1.76
Dividends & Yields
CervoMed pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -120.37%
- Earnings Yield
- -129.20%
Stock Price Statistics
- Beta
- -0.07
- 52-Week Price Change
- -83.80%
- 50-Day Moving Average
- 2.28
- 200-Day Moving Average
- 3.19
- Relative Strength Index (RSI)
- 37.30
- Average Volume (3m)
- 485.21K
Important Dates
CervoMed upcoming earnings date is Apr 05, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 09, 2026
- Next Earnings Date
- Apr 05, 2027
- Ex-Dividend Date
- ―
Financial Position
CervoMed as a current ratio of 4.91, with Debt / Equity ratio of 0.00%
- Current Ratio
- 4.91
- Quick Ratio
- 4.91
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.31
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, CervoMed has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
CervoMed EV to EBITDA ratio is -0.56, with an EV/FCF ratio of -0.60.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.56
- EV to Free Cash Flow
- -0.60
- EV to Operating Cash Flow
- -0.60
Balance Sheet
CervoMed has $19.60M in cash and marketable securities with $0.00 in debt, giving a net cash position of $19.60M billion.
- Cash & Marketable Securities
- $19.60M
- Total Debt
- $0.00
- Net Cash
- $19.60M
- Net Cash Per Share
- $1.30
- Tangible Book Value Per Share
- $1.15
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for CervoMed is $15.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $15.25
- Price Target Upside
- 944.52% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- -99.86%
- EPS Growth Forecast
- 4.48%
Scores
- Smart Score
- ―
- AI Score
- 45

